Focused Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-40
| Closed | -$3.86K | – | 819 |
|
|
2023
Q4 | $3.86K | Hold |
40
| – | – | ﹤0.01% | 670 |
|
|
2023
Q3 | $4.85K | Hold |
40
| – | – | ﹤0.01% | 624 |
|
|
2023
Q2 | $4.58K | Hold |
40
| – | – | ﹤0.01% | 654 |
|
|
2023
Q1 | $5.51K | Sell |
40
-110
| -73% | -$15.2K | ﹤0.01% | 625 |
|
|
2022
Q4 | $19.4K | Hold |
150
| – | – | ﹤0.01% | 425 |
|
|
2022
Q3 | $17K | Sell |
150
-162
| -52% | -$18.4K | ﹤0.01% | 421 |
|
|
2022
Q2 | $23K | Sell |
312
-1
| -0.3% | -$74 | ﹤0.01% | 377 |
|
|
2022
Q1 | $24K | Sell |
313
-2,656
| -89% | -$204K | ﹤0.01% | 405 |
|
|
2021
Q4 | $267K | Sell |
2,969
-393
| -12% | -$35.3K | 0.04% | 147 |
|
|
2021
Q3 | $311K | Sell |
3,362
-253
| -7% | -$23.4K | 0.05% | 122 |
|
|
2021
Q2 | $281K | Sell |
3,615
-407
| -10% | -$31.6K | 0.05% | 135 |
|
|
2021
Q1 | $300K | Buy |
4,022
+2,438
| +154% | +$182K | 0.05% | 129 |
|
|
2020
Q4 | $270K | Sell |
1,584
-294
| -16% | -$50.1K | 0.05% | 132 |
|
|
2020
Q3 | $264K | Sell |
1,878
-5,465
| -74% | -$768K | 0.06% | 123 |
|
|
2020
Q2 | $1.18M | Sell |
7,343
-73
| -1% | -$11.7K | 0.27% | 47 |
|
|
2020
Q1 | $725K | Sell |
7,416
-53
| -0.7% | -$5.18K | 0.21% | 55 |
|
|
2019
Q4 | $964K | Sell |
7,469
-647
| -8% | -$83.5K | 0.23% | 55 |
|
|
2019
Q3 | $611K | Sell |
8,116
-964
| -11% | -$72.6K | 0.17% | 72 |
|
|
2019
Q2 | $1.38M | Sell |
9,080
-926
| -9% | -$141K | 0.37% | 43 |
|
|
2019
Q1 | $1.19M | Buy |
10,006
+240
| +2% | +$28.6K | 0.36% | 45 |
|
|
2018
Q4 | $1.07M | Buy |
9,766
+585
| +6% | +$63.9K | 0.36% | 47 |
|
|
2018
Q3 | $1.48M | Buy |
+9,181
| New | +$1.48M | 0.5% | 39 |
|